pharma bees parallel channel view- retesting parallel channel support line & pivot S1 in daily chart.
- either it may go up or down as per market direction.
- inverted head and shoulder are hidden future.
I don't recommend & taking trade based on this idea.
consult your SEBI registered adviser to Know the market risk before trade.
Key stats
About NIPPONAMC - NETFPHARMA
Home page
Inception date
Jul 2, 2021
Structure
Open-Ended Fund
Replication method
Physical
Primary advisor
Nippon Life India Asset Management Ltd. (Invt Mgmt)
ISIN
INF204KC1089
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errs. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Classification
For investmentPharma index is on up move.
I do not have time to study companies for investment.
I have been investing in Pharma Bees from 5 months. 100 units every month.
We will definitely get 1500 - 2000/- in at least one trade. Instead of reinvesting into trading I am directing to PHARMABEES.
My view is:
1.
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.